REVIEW OF: Zhang A et al, Harm Reduct J 2025;22:89

STUDY TYPE: Systematic review

Vending machines that stock harm reduction supplies are showing up in pharmacies, libraries, and jails across the US. But how much do we actually know about whether they work?

Across 30 studies (190,000+ participants), mostly non-US, machines dispensed such supplies as sterile syringes, naloxone, HIV self-tests, and condoms. Outcomes included feasibility, acceptability, reach, and real-world impact.

Machines distributed large supply volumes, often outside business hours, sometimes exceeding the reach of in-person programs. Users valued privacy, anonymity, and 24/7 access. Machines reliably reached high-risk, younger, and marginalized populations, including those who would avoid traditional health care. Community concerns about increased crime or drug use were generally unsupported by available data.

Outcome measures were sparser but still encouraging: Syringe vending programs reduced sharing and, in some studies, drug use. Two studies reported fewer fatal overdoses after naloxone vending machine implementation. HIV self-test distribution identified new infections, with positivity rates ranging from around 2% to 18%.

CARLAT TAKE
The evidence base here mostly consists of feasibility data, not efficacy trials, but that’s not surprising. This population is hard to study, and RCTs of harm reduction tools aren’t always practical or even ethical. Getting harm reduction supplies into the hands of someone who won’t walk into a clinic, at 2 am, anonymously, is a win. If your community is considering vending machines as part of a broader harm reduction strategy, the case for moving forward is reasonable even without definitive outcome data.